| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |